4 reports

Patients were randomized to one of three groups; one group received ## mg tildrakizumab, one received ## mg and one received an inactive placebo.

  • Autoimmune Disease
  • Monoclonal Antibody
  • Therapy
  • United States
  • Novartis AG

The molecules developed by Companies in Pre-Registration, Phase III, Phase I, Preclinical, Discovery and Unknown stages are ##, ##, ##, ##, ## and ## respectively.

  • Autoimmune Disease
  • Monoclonal Antibody
  • Therapy
  • United States
  • Novartis AG

ONE UNIT REFERS TO ONE CLIP.

  • Autoimmune Disease
  • Health Services
  • Hospital
  • Therapy
  • Market Size
  • EUROPE: ANEMIA MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)

COLLABORATIONS, & EXPANSIONS ARE FUELING MARKET GROWTH, 2014 & 2015 No. of New Product Launches No. of FDA approvals Expansions and Acquisitions ## ## ## 2014 ## ## ## 2015 ## ## NO.

  • Autoimmune Disease
  • Hospital
  • Europe
  • World
  • Market Size